focus -WSS

focus

author：fashion 2025-09-29 16:35:06 - browse：33

CHICAGO — The Food and Drug Administration’s top oncologist reiterated that the agency doesn’t want drugmakers applying for approval with data from trials solely run in a single country such as China, but instead wants to see companies conducting studies across the world.

The comments by Richard Pazdur, director of the FDA’s Oncology Center of Excellence, came as more drugmakers report data from China, with Miami-based Summit Therapeutics earlier this week announcing that its investigational drug beat Merck’s blockbuster Keytruda in a head-to-head non-small cell lung cancer study in China.

It’s not a blanket policy, and the agency would assess each company’s submission to see how applicable the data are to the U.S. population, but in general, “I am pro multi-regional trials,” Pazdur said Friday at STAT@ASCO, STAT’s event at the American Society of Clinical Oncology annual meeting.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： BMS, looking to build heart drug business, turns to AI for diagnosis

focus

leisure time

WSS

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Faced with fears of OxyContin misuse, sales reps touted its safety

Newly revealed memo details efforts to keep Trump in power following election loss

Be careful with at

Timeline: Special counsel's investigation into Trump's handling of classified documents

GOP presidential candidates start declaring their loyalty

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Affirmative action in medical school literally saved lives

Maui funeral service workers on devastation of fires: 'I'm in shock'

United colonoscopy coverage change 'may cost lives,' doctors say

After John Oliver segment, STAT readers share their opioid

Continuity nursing helped my family in our darkest PICU moments

Be careful with at

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Idaho college killings prosecutors challenge defense's grand jury claims

What does generative AI mean for health care? We asked experts

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

leisure time

Pharma budget tightening trickles down to Doximity

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

TB outbreak tied to bone grafts underscores testing shortcomings

YouTube cracks down on misinformation on cancer treatment

Senators push IRS to launch nonprofit hospital probe

Covid's long

focus

focus

leisure time

hotspot